Securities

Hemispherx Can't Duck Suit Over $2.1M Exec Bonuses

A Delaware Chancery judge on Tuesday refused to throw out a shareholder suit challenging Hemispherx Biopharma Inc.'s $2.1 million in bonuses for executives who led a doubling of the biotech's market capitalization, saying too many questions remain ...read more